Dian L. Olson

2.1k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Dian L. Olson is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Dian L. Olson has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Immunology and Allergy. Recurrent topics in Dian L. Olson's work include Cell Adhesion Molecules Research (6 papers), Immune Cell Function and Interaction (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Dian L. Olson is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Immune Cell Function and Interaction (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Dian L. Olson collaborates with scholars based in United States, Italy and Switzerland. Dian L. Olson's co-authors include Linda C. Burkly, Catherine Hession, Richard Tizard, Lynn Ogata, Christina R. Reilly, David Lo, Richard A. Flavell, Ulla-Angela Temann, Sunil K. Joshi and Pandelakis A. Koni and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dian L. Olson

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of relB is required for the development of thymic medulla and dendritic cells

1995 650 citations Linda C. Burkly, Catherine Hession et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dian L. Olson United States	15	890	764	383	328	188	18	1.8k
Frank C. Stomski Australia	23	800 0.9×	727 1.0×	463 1.2×	103 0.3×	254 1.4×	35	1.8k
Laura V. Doyle United States	17	748 0.8×	500 0.7×	393 1.0×	272 0.8×	173 0.9×	27	1.5k
Cinda M. Boyer United States	18	656 0.7×	620 0.8×	537 1.4×	260 0.8×	104 0.6×	31	1.5k
Sandra Coral Italy	25	1.1k 1.2×	1.6k 2.0×	691 1.8×	270 0.8×	176 0.9×	53	2.3k
Luigi Scotto United States	30	1.1k 1.2×	1.5k 2.0×	642 1.7×	280 0.9×	170 0.9×	82	2.8k
Yu-Chung Yang United States	18	488 0.5×	860 1.1×	320 0.8×	225 0.7×	316 1.7×	21	1.6k
Keiko Okuda Japan	24	717 0.8×	949 1.2×	651 1.7×	180 0.5×	1.2k 6.3×	67	2.6k
Sally D. Lyn United States	6	778 0.9×	1.1k 1.5×	454 1.2×	331 1.0×	55 0.3×	8	1.8k
Fiona H. Durie United States	13	1.6k 1.8×	309 0.4×	312 0.8×	179 0.5×	202 1.1×	14	2.2k
Shalley K. Gupta United States	12	497 0.6×	392 0.5×	529 1.4×	103 0.3×	82 0.4×	15	1.1k

Countries citing papers authored by Dian L. Olson

Since Specialization

Citations

This map shows the geographic impact of Dian L. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian L. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian L. Olson more than expected).

Fields of papers citing papers by Dian L. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian L. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian L. Olson. The network helps show where Dian L. Olson may publish in the future.

Co-authorship network of co-authors of Dian L. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Dian L. Olson. A scholar is included among the top collaborators of Dian L. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian L. Olson. Dian L. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Olson, Dian L., Yaping Sun, Dingyi Wen, et al.. (2011). An antibody–cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours. European Journal of Cancer. 47(11). 1736–1746. 30 indexed citations

2.

Podar, Klaus, Mariateresa Fulciniti, Giovanni Tonon, et al.. (2011). The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications. British Journal of Haematology. 155(4). 438–448. 62 indexed citations

3.

Sun, Chao, Olivia Orozco, Dian L. Olson, et al.. (2008). CRIPTO3, a presumed pseudogene, is expressed in cancer. Biochemical and Biophysical Research Communications. 377(1). 215–220. 23 indexed citations

4.

Olson, Dian L., Linda C. Burkly, Diane R. Leone, Brian Dolinski, & Roy R. Lobb. (2005). Anti-alpha4 integrin monoclonal antibody inhibits multiple myeloma growth in a murine model.. PubMed. 4(1). 91–9. 51 indexed citations

5.

Olson, Dian L., Linda C. Burkly, Diane R. Leone, Brian Dolinski, & Roy R. Lobb. (2005). Anti-α4 integrin monoclonal antibody inhibits multiple myeloma growth in a murine model. Molecular Cancer Therapeutics. 4(1). 91–99. 47 indexed citations

6.

Adkins, Heather B., Caterina Bianco, Susan G. Schiffer, et al.. (2003). Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. Journal of Clinical Investigation. 112(4). 575–587. 134 indexed citations

7.

Schneider, Pascal, Dian L. Olson, Aubry Tardivel, et al.. (2003). Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL). Journal of Biological Chemistry. 278(7). 5444–5454. 101 indexed citations

8.

Adkins, Heather B., Caterina Bianco, Susan G. Schiffer, et al.. (2003). Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. Journal of Clinical Investigation. 112(4). 575–587. 6 indexed citations

9.

Wang, Li‐Chun, Fatiha Nassir, Leona Ling, et al.. (2002). Disruption of hedgehog signaling reveals a novel role in intestinal morphogenesis and intestinal-specific lipid metabolism in mice. Gastroenterology. 122(2). 469–482. 62 indexed citations

10.

Koni, Pandelakis A., Sunil K. Joshi, Ulla-Angela Temann, et al.. (2001). Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice. The Journal of Experimental Medicine. 193(6). 741–754. 412 indexed citations

11.

Jakubowski, Aniela, Dian L. Olson, Susan L. Kalled, et al.. (1998). Molecular Mapping with Functional Antibodies Localizes Critical Sites on the Human IL Receptor Common γ (γc) Chain. The Journal of Immunology. 161(7). 3474–3483. 14 indexed citations

12.

Baker, Darren P., Adrian Whitty, Mohammad Zafari, et al.. (1998). The Murine Anti-Human Common γ Chain Monoclonal Antibody CP.B8 Blocks the Second Step in the Formation of the Intermediate Affinity IL-2 Receptor. Biochemistry. 37(41). 14337–14349. 5 indexed citations

13.

Jakubowski, Aniela, Irene Sizing, Dian L. Olson, et al.. (1998). Molecular mapping with functional antibodies localizes critical sites on the human IL receptor common gamma (gamma c) chain.. PubMed. 161(7). 3474–83. 15 indexed citations

14.

Whitty, Adrian, Dian L. Olson, Christopher W. Borysenko, et al.. (1998). Interaction affinity between cytokine receptor components on the cell surface. Proceedings of the National Academy of Sciences. 95(22). 13165–13170. 33 indexed citations

15.

Reimann, Keith A., Wenyu Lin, Sandra L. Bixler, et al.. (1997). A Humanized Form of a CD4-Specific Monoclonal Antibody Exhibits Decreased Antigenicity and Prolonged Plasma Half-Life in Rhesus Monkeys While Retaining Its Unique Biological and Antiviral Properties. AIDS Research and Human Retroviruses. 13(11). 933–943. 62 indexed citations

16.

Reimann, Keith A., et al.. (1995). In Vivo Administration of CD4-Specific Monoclonal Antibody: Effect on Provirus Load in Rhesus Monkeys Chronically Infected with the Simian Immunodeficiency Virus of Macaques. AIDS Research and Human Retroviruses. 11(4). 517–525. 20 indexed citations

17.

Burkly, Linda C., Catherine Hession, Lynn Ogata, et al.. (1995). Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373(6514). 531–536. 650 indexed citations breakdown →

18.

Lobb, Roy R., et al.. (1993). Cloning of an inflammation-specific phosphatidyl inositol-linked form of murine vascular cell adhesion molecule-1.. Journal of Biological Chemistry. 268(12). 8835–8841. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact